Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Exercise/Conversion of 12,500 BCAX shares, $47.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 12,500 | $47.4K |
| Jul 10, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 12,500 | $47.4K |
| May 26, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 9,200 | $34.9K |
| Apr 22, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 9,200 | $34.9K |
| Mar 24, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 9,200 | $34.9K |
| Mar 6, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 7,318 | $27.7K |
| Feb 4, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 125,000 | n/a |
| Jan 26, 2026 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 1,882 | $7.1K |
| Dec 23, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 9,200 | $34.9K |
| Nov 25, 2025 | Bicara Therapeutics Inc. (BCAX) | Exercise/Conversion | 605 | $2.3K |